Expression of CK19 in invasive breast carcinomas of special histological types: Implications for the use of one-step nucleic acid amplification

Journal of Clinical Pathology

Volumn 64, Issue 6, 2011, Pages 493-497

  Alvarenga, César A ^a,b   Paravidino, Paula I ^a,b   Alvarenga, Marcelo ^a,c   Dufloth, Rozany ^d   Gomes, Madalena ^b   Zeferino, Luiz C ^c   Schmitt, Fernando ^b,e  

^a Instituto de Patologia de Campinas   (Brazil)

^b UNIVERSITY OF PORTO   (Portugal)

^c UNIVERSITY OF CAMPINAS   (Brazil)

^d PONTIFÍCIA UNIVERSIDADE CATÓLICA DE CAMPINAS   (Brazil)

^e University of Porto   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKERATIN 19;

APOCRINE CARCINOMA; ARTICLE; BREAST CARCINOMA; HISTOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; MIXED TUMOR; MUCINOUS CARCINOMA; NUCLEIC ACID AMPLIFICATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; TISSUE MICROARRAY;

BREAST NEOPLASMS; CARCINOMA; FEMALE; HUMANS; KERATIN-19; NEOPLASM INVASIVENESS; NUCLEIC ACID AMPLIFICATION TECHNIQUES; SENTINEL LYMPH NODE BIOPSY; TISSUE ARRAY ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 79956301176     PISSN: 00219746     EISSN: 14724146     Source Type: Journal    
DOI: 10.1136/jcp.2011.089862     Document Type: Article

References (19)

1. Weigelt B, Reis-Filho JS. Histological and molecular types of breast cancer: is there a unifying taxonomy? Nat Rev Clin Oncol 2010;6:718-30.
2. Reis-Filho JS, Lakhani SR. Breast cancer special types: why bother? J Pathol 2008;216:394-8.
3. Simpson PT, Reis-Filho JS, Gale T, et al. Molecular evolution of breast cancer. J Pathol 2005;205:248-54.
4. Vargo-Gogola T, Rosen JM. Modelling breast cancer: one size does not fit all. Nat Rev Cancer 2007;7:659-72. (Pubitemid 47327411)
5. Ellis P, Schnitt SJ, Sastre-Garau X, et al. Invasive breast carcinoma. In: Tavassoli FA, Devilee P, eds. WHO Classification of Tumours. Pathology and Genetics of Tumours of the Breast and Female Genital Organs. Lyon: Lyon Press, 2003.
6. Chu PG, Weiss LM. Keratin expression in human tissues and neoplasms. Histopathology 2002;40:403-39. (Pubitemid 34535443)
7. Schem C, Maass N, Bauershlag DO, et al. One-step nucleic acid amplification - a molecular method for the detection of lymph node metastases in breast cancer patients; results of the German study group. Virchows Arch 2009;454:203-10.
8. Tsujimoto M, Nakabayashi K, Yoshidome K, et al. One-Step Nucleic Acid Amplification (OSNA) for intraoperative detection of lymph node metastasis in breast cancer patients. Clin Can Res 2007;13:4807-16. (Pubitemid 47294788)
9. Visser M, Jiwa M, Horstman A, et al. Intra-operative rapid diagnostic method based on CK 19 mRNA expression for the detection of lymph node metastases in breast cancer. Int J Cancer 2008;122:2562-7. (Pubitemid 351590490)
10. Noguchi M. Sentinel lymph node biospsy as an alternative to routine axillay lymph node dissection in breast cancer patients. J Surg Oncol 2001;76:144-56.
11. Veronesi U, Paganelli G, Vialle G, et al. A randomized comparacion of sentinel-node biopsy with routine axillary dissection in breast cancer. N Engl J Med 2003;349:546-53. (Pubitemid 36951366)
12. Fisher B, Anderson S, Bryant J, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for treatment of invasive breast cancer. N Engl J Med 2002;347:1233-41. (Pubitemid 35176242)
13. Weigelt B, Verduijn P, Bosma A, et al. Detection of metastases in sentinel lymph nodes of breast cancer patients by multiple mRNA markers. Br J Cancer 2004;39:1654-67.
14. Gillander WE, Mikhitarian K, Hebert R, et al. Molecular detection of micrometastatic breast cancer in histopathology-negative axillary lymph nodes correlates with traditional predictors of prognosis: an interim analysis of a prospective multi-institutional cohort study. Ann Surg 2004;239:828-37. discussion 837-40.
15. Abdul-Rassol S, Kidson SH, Panieri E, et al. An evaluation of molecular markers for improved detection of breast cancer metastases in sentinel nodes. J Clin Pathol 2006;59:289-97. (Pubitemid 43344892)
16. Su L, Morgan P, Lane B. Expression of cytokeratin messenger RNA versus protein in the normal mammary gland and in breast cancer. Hum Pathol 1996;27:800-6.
17. Heatley M, Maxwell P, Whiteside C, et al. Cytokeratin intermediate filament expression in benign and malignant breast disease. J Clin Pathol 1995;48:26-32.
18. Kwaspen FH, Smedts FM, Broos A, et al. Reproducible and highly sensitive detection of the broad spectrum epithelial marker keratin 19 in routine cancer diagnosis. Histopathology 1997;31:503-16. (Pubitemid 28008013)
19. Tot T. The cytokeratin profile of medullary carcinoma of the breast. Histopathology 2000;37:175-81. (Pubitemid 30608517)